Human periodontitis is a chronic infectious disease that is characterized by plaque induced destruction of periodontal soft tissue and alveolar bone. The etiology of the disease is unclear but is commonly believed to be bacterial infection interacts with host defense which is modified by a multitude of agents, such as genetic, behavioral, and environmental factors (1) . In the past decade, many studies have been carried out to investigate genetic susceptibility to periodontal diseases. In this respect, one of the most extensively studied gene families is that of the Fc gamma receptor (FcγR), which has been proven to be essential in the pathogenesis of periodontal disease. In this review, we summarize current genetic association studies on the FcγR gene family and other genes in its immune network. We hope the review will give readers a general idea of the association between FcγR and periodontitis, as well as the current status of genetic study in periodontology and its future directions.
Periodontitis is a complex disease
A classification system based on genetic involvement puts diseases into three categories: chromosomal, Mendelian, and complex (2) . Chromosomal disorders are characterized by gross abnormalities in chromosome number or structure, and often result in preterm death related to developmental abnormalities. Mendelian disorders are caused by a few rare mutations of a single gene or, exceptionally, of more than one gene (3, 4) . Mendelian disorders usually display familial patterns of inheritance, including autosomal recessive, autosomal dominant, or X-linked transmission of the disease-related alleles, and there is a direct correlation between genotype and phenotype. It is generally accepted that complex M a n u s c r i p t p r o o f 4 diseases have a multifactorial pathogenesis and develop as a result of the interplay between several genes or genetic variants and environmental factors (including bacterial infection and smoking), somatic mutations, and epigenetic modifications (5) . Thus, inherited genetic variation is not the direct cause of a complex disease but instead mediates the risk of disease development in response to exposure to one or more environmental factors. Therefore the clinical and genetic heterogeneity of such disorders makes the analysis of their exact causes extremely difficult (6) (Figure 1 ).
Genetic factors can influence the intensity and severity of host responses to bacterial challenge, which may result in various levels of periodontal tissue destruction.
As a consequence, different patients might exhibit different levels of immune responses to the same level of infection (7) (8) (9) . Specifically, different allelic variants can lead to variations in different aspects of host immune responses such as innate immunity, adaptive immunity, and auto-immune reaction (10) . Genetic variations may also serve as either protective or risk factors for diseases such as periodontitis (11) . For these reasons, periodontitis is considered a complex disease whose phenotype is determined by both genetic make-up and environmental influences on the host bacterial interaction within an individual. Therefore, genetic polymorphism studies of periodontitis need careful design and cautious interpretation (9) .
Genetic polymorphism study of complex human diseases
Until the availability of detailed genetic maps thanks to the Human Genome Project, the identification of DNA mutations that caused rare disorders, such as cystic fibrosis and Huntington's disease depended on genetic linkage and positional cloning studies (12) (13) (14) (15) . M a n u s c r i p t p r o o f 5 However, such approaches were unsuccessful in identifying loci that contribute to complex diseases. In 1996, Risch and Merikangas suggested that association studies could be more powerful than linkage studies in identifying susceptibility loci (16) .
Furthermore, some researchers postulated the hypothesis that common variants are the base of common diseases, suggesting that common DNA variation, as opposed to rare mutations, could be responsible for a proportion of common diseases (17) (18) (19) . Although that hypothesis remains controversial, resources for association studies, such as dense genetic maps of single nucleotide polymorphisms (SNPs) across the human genome, enable investigators to more rapidly identify disease-associated loci that could have a major impact on public health (20) . Association studies are currently the focus of most study designs for identifying loci involved in complex diseases such as cardiovascular diseases, diabetes, cancer, and periodontal diseases.
There are two approaches for studying candidate SNPs: direct and indirect. In the direct association study, the proposed causative SNP is genotyped directly. Despite the proven success of the direct approach using non-synonymous (non-synonymous change may either be missense or nonsense, where a missense change in the coding sequence results in a different amino acid, while a nonsense change in the coding sequence results in a premature stop codon) SNPs (21), a major challenge is predicting or determining a priori which SNPs are likely to be causative or predictive of the phenotype of interest, in particular, since our current knowledge about the pathogenesis of most complex diseases and SNP functions is limited. Hence, the selection of the candidate SNPs is usually difficult. The indirect approach, on the other hand, is much like a linkage study in that it assays multiple markers while assuming them to be neutral, without assuming the M a n u s c r i p t p r o o f 6 location of the causative gene or locus (22) . It is most often a case-control study on subjects drawn from the general population and uses a measure of allelic association or site correlation (known as linkage disequilibrium, LD) to detect historical recombination.
This strategy, however, also has some problems: sample selection reduces statistical power, particularly for rare alleles; haplotypes at multiple loci cannot be resolved, thereby precluding some powerful mapping strategies; and clinical samples are less readily analyzable using stratification by phenotypic differences and environmental factors, which may be critical to understanding disease susceptibility (23) .
Among recent developments in genomic research is the genome-wide association study (GWAS), which seems more promising than traditional association studies in identifying molecular pathways of diseases, and in a lesser extent, risk variants of complex diseases since it scans the whole genome for association without any prior assumptions about the biological process, hence can possibly find out those variants would not usually be suspected to be associated based on our current limited knowledge of the biological functions of the genes (24) . However, researchers are still debating the usefulness of the GWAS in actually helping to predict individual genetic risk of complex diseases because most of GWASs carried out so far have not identified variants by which we can accurately predict genetic risks since the associated variants found out are common and typically have very small effects on the variability of the traits, hence can explain only a small portion of the heritability (25) (26) (27) . The majority of effect sizes of risk alleles that have been found so far in GWASs are small: typically with an odds ratio of <1.5, and with many around 1.1 and 1.2, which represent the limit of detection given the experimental sample sizes employed to date. Alternatively, an individual identified gene M a n u s c r i p t p r o o f 7 variant results to only 10% to 20% more susceptible to a certain disease. Those findings suggested that many GWAS so far may not have sufficient power to discover associations with such small effects ( Figure 2 ) (28). Larger-scale GWASs (sample size of more than 10,000) are thus required (27) . Moreover, for most diseases, GWAS results usually indicate a substantial number of variants that generate small increases in disease risk; such variants cannot individually explain much of the genetic variance.
Therefore, a combined strategy such as one using rare and low-frequency variants and structure variants may be required (26, 27) . A recent combination approach used in diabetes research may show us a possible effective strategy (29) . In that study, the researchers used GWAS to investigate 12,000 common non-synonymous SNPs in patients with type I diabetes and healthy controls. They identified a type I diabetesassociated locus on chromosome 2q24 and subsequently used a newly developed highthroughput sequencing technology to resequence the candidate genes in the associated locus. The group found that multiple rare variants in the "interferon-induced with helicase C domain 1" gene (IFIH1) was associated with type I diabetes and implicated involvement of the gene in this disease. These associations explained a substantial portion of disease risk and constituted proof of principle for the genome-wide approach and gene fine mapping in the elucidation of complex diseases (29) .
Genetic polymorphism study of periodontitis
In the past decade, many association studies on periodontitis have been reported.
However, owing to the complicated nature of the disease and the limitations of the study approaches used, our knowledge of the genetic background of periodontitis is still scant The general characteristics of human FcγRs are summarized in Table 1 . The paired expression of activating and inhibitory molecules on the same cell is the key for the generation of a balanced immune response (48) . As a consequence, T cells and NK cells may become activated; a variety of cytokines and chemokines may also be released (51) . Because FcγRs on leukocytes in effect link cellular and humoral branches of the immune system, they can be considered to be an essential component of the host-defense mechanism against bacteria (31) . Therefore, any alteration in FcγR expression and function would alter host immune responses against periodontal pathogens and hence susceptibility to periodontal diseases.
Fc gamma receptor polymorphisms

Biology of Fc gamma receptors
Fc gamma receptors and periodontitis
Since the recent realization that FcγRIV is a highly conserved member of the FcγR family, researchers have begun refocusing on the affinity of individual Fc receptors for different antibody isotypes (52) . One hypothesis is that the low-affinity inhibitory 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 IgG-coated surfaces compared with those from donors with less than two (72) . The copy number variation of FCGR3B has been reported to be associated with several chronic inflammatory diseases such as SLE (72), rheumatoid arthritis (73) and immune-mediated glomerulonephritis (74) . FCGR2C copy number variation is found to be associated with idiopathic thrombocytopenic purpura (75) . The same study also reported that NK cells from individuals with two or three copies of FCGR3A seem to express higher levels of receptor and exhibit greater antibody-dependent killing capacity than those from individuals with one copy of the gene (75) . It should be noticed that although a number of studies have made use of well validated complementary techniques for the assessment of copy number variation, there is controversy on the accuracy and sensitivity of some of these techniques, as they are still at an early stage of technical development.
Fc gamma receptor polymorphisms
Fc gamma receptor polymorphisms and periodontitis
Most studies on the association between genetic polymorphisms of FcγRs and periodontitis are based on the bi-allelic polymorphisms mentioned above. Studied groups have come from Caucasian, African-American, Japanese, and Chinese populations.
Different definitions of periodontitis that have been used include early onset (31, (76) (77) (78) (79) (80) (81) (82) (83) (84) (85) (86) (87) (88) (Table 3) . Unsurprisingly, the differing populations, periodontitis types, and study designs have led to mixed conclusions (89) Moreover, it should be noticed that FcγRIIb polymorphisms may also play an important role in the pathogenesis of periodontitis, because there are large numbers of FcγRII-bearing B lymphocytes in periodontal lesions and FcγRIIb is so far the only known inhibitory receptor in the FcγR family that is pivotal in the regulation of B cell activation. 15 Indeed, an association between FcγRIIb-232T and aggressive periodontitis has been shown in Japanese subjects (89, 91) .
Genetic polymorphisms within the Fc gamma receptor regulatory network
As shown in Table 2 The following sections will discuss genetic polymorphisms within the FcγR regulatory network in detail.
Upregualtory factors
Interleukin-1 family
The biological activity, molecular biology, and clinical relevance of the IL-1 family have been studied extensively. IL-1 is a potent pro-inflammatory cytokine that is released by macrophages, platelets, and endothelial cells. The gene encoding this cytokine lies on chromosome 2q13-21 (92) (93) (94) . In 1997, Kornman et al reported an association between polymorphisms in the genes encoding IL-1α (-889) (rs1800587) and IL-1β (Y3953) (rs1143634) (termed the "composite genotype") and an increased severity of periodontitis (95) . This initial study has been highly influential in arousing interest in gene (98) . The same metaanalysis also found a weak positive association with IL-1β (-511) (rs16944) (98) .
Tumor necrosis factor
TNF is a pro-inflammatory cytokine that possesses a wide range of immunoregulatory functions. It has the potential to stimulate the production of secondary mediators, including chemokines or cyclooxygenase products, which consequently amplify the degree of inflammation (99, 100) . The TNF gene is located on chromosome 6 within the 
Miscellaneous factors
Studies on IFN-γ -874T/A (rs2430561) and chronic periodontitis have shown mostly negative results (111) (112) (113) . A study on the IL-13 promoter polymorphisms -1112C/T (rs1800925) and -1512A/C (rs1881457) in aggressive periodontitis also did not show significant results (114) . Other inflammatory mediators such as C5 rs17611 have been found to be associated with severe chronic periodontitis in the Chinese population (115) .
Additionally, C5 1632C/T (rs25681) and 2404A/G (rs17611) have been found to be associated with bronchial asthma (116) , rs17611 and rs2300929 with liver fibrogenesis (117) .
Downregulatory factors
Interleukin-10
IL-10 stimulates the production of protective antibodies and downregulates proinflammatory cytokines produced by monocytes (118) (119) (120) . The gene encoding IL-10 has been mapped to chromosome 1q31-32 (121) . Three promoter SNPs have been described: -1087G/A (rs1800896), -819C/T (rs1800871), and -592C/A (rs1800872) (122, M a n u s c r i p t p r o o f 18 123 ). These three loci exhibit strong LD (124) . There is some evidence of association of such polymorphism with periodontitis, but only in particular populations (125-128).
Microsatellite polymorphisms have been identified in the 5'-flanking region of the gene, but no association with periodontitis has been established (108, 129) .
Transforming growth factor-β1
TGF-β1 is released during tissue injury and by inflammatory cells exposed to bacteria and their products (130) . It has both therapeutic and pathologic potential (131) . The gene is located on chromosome 19q13.1 (132) , and SNP -509C/T (rs1800469) has been reported to be associated with periodontitis in Brazilian Caucasians but not Czech Caucasians (133, 134) .
Interleukin-4
IL-4 can rescue B lymphocytes from apoptosis and enhance their survival, thus playing a role in promoting B cell mediated autoimmunity (111) . It is also a potent downregulator of macrophage function (135, 136) . The gene has been mapped to chromosome 5q31.1 (137), with a promoter SNP at position -590 (rs2243250) and a 70-bp variable-number tandem repeat polymorphism at intron 2 (11). Case-control reports relating to aggressive periodontitis and chronic periodontitis susceptibility and severity across several populations did not find a connection between these polymorphisms and periodontitis (138-142). have also been found to be associated with atopic diseases (147) . Whether any of these genetic polymorphisms are related to periodontitis still need further investigation.
Other regulatory members
Limitations and future directions
Other than genetic polymorphism studies, large-scale genomic screening and large scale population investigations in periodontal research, such as multi-community screening, are rare. The paucity of research may be due to the complex natural course of periodontitis, lack of a robust classification system, difficulties in searching matched controls, or other factors (30) . Most of the studies about FcγR polymorphisms and periodontitis have focused on single or several variations of the candidate genes in a certain population (e.g. studies listed in Table 3 ), and have provided vast quantities of diverse data that are difficult to interpret and lead to general conclusions. Even for the most extensively studied variations in the IL-1 cluster, meta-analysis can only give a positive conclusion in Caucasians (10, 98) . Moreover, the number of studies providing thorough data (e.g. allele type, genotype, haplotype) together with Hardy-Weinberg equilibrium and minor allele frequencies, is small. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Nonetheless, it is important to maintain a realistic perspective of the clinical utility of genetic information (148, 149) . In the future, researchers should also be cautious of numerous weak associations that may turn out to be spurious at repeated testing (150) . It is not enough that only the racial and ethnic backgrounds of the subjects are taken into account; studies must have sufficient numbers of cases and controls, with the controls carefully chosen to make the association between polymorphisms and periodontitis much clearer. The choice of candidate genes must also be justifiable and the data clearly presented to show the range of effect and risk attributable to the gene variation. In many currently published genetic association studies, the reported associated SNPs show no obvious function, thus providing few clues on pathogenesis. Recent developments in high-throughput target resequencing can overcome this limitation by searching for variants in targeted gene regions such as exons or other regions with known function (29) . Combination strategies can also be utilized, such as combination of genome-wide scanning and candidate gene strategy, to improve the both efficiency and efficacy of studies, especially periodontal genetic studies, for which it is usually difficult to screen a large population. It should be kept in mind that our knowledge of FcγR genetics is expanding, new technology for detecting different kind of variation is continually 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   M  a  n  u  s  c  r  i  p  t  p  r  o  o  f   21 developed. The most important task for us before we dig in is to understand these new knowledge and technology thoroughly and find a way to incorporate these knowledge and technology with the unique nature of periodontitis. Only that can help us to establish a reasonable and practical strategy for association study in periodontitis. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   M  a  n  u  s  c  r  i  p  t  p  r  o  o  f 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57 sample size over 11,000 cases and 11,000 controls could reach an accepted power of 0.8.
However when MAF is dropped to 0.1 (dark solid line), the required sample size is increased to 16,000 both case and control subjects (28) . When a disease is with 15-20% prevalence (dash lines, e.g. chronic periodontitis) and risk variant odds ratio is 1.2, MAF of 0.1-0.2 (between light and dark dash lines) means sample size of 1,500 -3,000 cases and controls could reach an acceptable power of 0.8. Therefore most of the GWAS today, particularly those for periodontitis, may not have sufficient power to detect genetic association of complex diseases with small effects. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
